Stock Track | Zepp Health Plunges 5.56% Despite Strong Q3 Revenue Growth, Q4 Outlook Raises Concerns

Stock Track11-05

Zepp Health Corporation (NYSE: ZEPP) saw its stock plummet 5.56% in trading on Tuesday, despite reporting robust revenue growth for the third quarter of 2025. The sharp decline suggests investors may have concerns about the company's profitability and future outlook.

The wearable technology company announced unaudited financial results for Q3 2025, with revenue reaching $75.8 million, representing a significant 78.5% year-over-year increase. Zepp Health also reported an improved gross margin of 38.2% for the quarter. However, the company still recorded a net loss attributable to Zepp Health of $1.6 million, albeit narrower than the $13.3 million loss in the same period last year.

While Zepp Health showed progress towards profitability, with adjusted operating income reaching breakeven at $0.4 million, investors may be focusing on the company's guidance for the fourth quarter. Zepp Health expects Q4 2025 revenue to be between $82.0 million and $86.0 million, representing a year-over-year increase of 38% to 45%. This projection, while still indicating strong growth, may have fallen short of some analysts' expectations, potentially contributing to the stock's decline.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1101151083?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101151083","market":"sg","top_or_hot":-1,"title":"Stock Track | Zepp Health Plunges 5.56% Despite Strong Q3 Revenue Growth, Q4 Outlook Raises Concerns","media":"Stock Track","content":"<p>Zepp Health Corporation (NYSE: ZEPP) saw its stock plummet 5.56% in trading on Tuesday, despite reporting robust revenue growth for the third quarter of 2025. The sharp decline suggests investors may have concerns about the company's profitability and future outlook.</p>\n\n<p>The wearable technology company announced unaudited financial results for Q3 2025, with revenue reaching $75.8 million, representing a significant 78.5% year-over-year increase. Zepp Health also reported an improved gross margin of 38.2% for the quarter. However, the company still recorded a net loss attributable to Zepp Health of $1.6 million, albeit narrower than the $13.3 million loss in the same period last year.</p>\n\n<p>While Zepp Health showed progress towards profitability, with adjusted operating income reaching breakeven at $0.4 million, investors may be focusing on the company's guidance for the fourth quarter. Zepp Health expects Q4 2025 revenue to be between $82.0 million and $86.0 million, representing a year-over-year increase of 38% to 45%. This projection, while still indicating strong growth, may have fallen short of some analysts' expectations, potentially contributing to the stock's decline.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Zepp Health Plunges 5.56% Despite Strong Q3 Revenue Growth, Q4 Outlook Raises Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Zepp Health Plunges 5.56% Despite Strong Q3 Revenue Growth, Q4 Outlook Raises Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-05 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zepp Health Corporation (NYSE: ZEPP) saw its stock plummet 5.56% in trading on Tuesday, despite reporting robust revenue growth for the third quarter of 2025. The sharp decline suggests investors may have concerns about the company's profitability and future outlook.</p>\n\n<p>The wearable technology company announced unaudited financial results for Q3 2025, with revenue reaching $75.8 million, representing a significant 78.5% year-over-year increase. Zepp Health also reported an improved gross margin of 38.2% for the quarter. However, the company still recorded a net loss attributable to Zepp Health of $1.6 million, albeit narrower than the $13.3 million loss in the same period last year.</p>\n\n<p>While Zepp Health showed progress towards profitability, with adjusted operating income reaching breakeven at $0.4 million, investors may be focusing on the company's guidance for the fourth quarter. Zepp Health expects Q4 2025 revenue to be between $82.0 million and $86.0 million, representing a year-over-year increase of 38% to 45%. This projection, while still indicating strong growth, may have fallen short of some analysts' expectations, potentially contributing to the stock's decline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZEPP","symbol_name":"华米科技","start_time":0,"source_url":"","article_id":"1101151083","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101151083","pubTimestamp":1762306438,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Zepp Health Corporation (NYSE: ZEPP) saw its stock plummet 5.56% in trading on Tuesday, despite reporting robust revenue growth for the third quarter of 2025. The sharp decline suggests investors may...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZEPP":"华米科技"},"translate_title":"个股追踪|Zepp Health尽管Q3营收增长强劲仍暴跌5.56%，Q4前景引担忧","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZEPP":1},"content_text":"Zepp Health Corporation (NYSE: ZEPP) saw its stock plummet 5.56% in trading on Tuesday, despite reporting robust revenue growth for the third quarter of 2025. The sharp decline suggests investors may have concerns about the company's profitability and future outlook.\nThe wearable technology company announced unaudited financial results for Q3 2025, with revenue reaching $75.8 million, representing a significant 78.5% year-over-year increase. Zepp Health also reported an improved gross margin of 38.2% for the quarter. However, the company still recorded a net loss attributable to Zepp Health of $1.6 million, albeit narrower than the $13.3 million loss in the same period last year.\nWhile Zepp Health showed progress towards profitability, with adjusted operating income reaching breakeven at $0.4 million, investors may be focusing on the company's guidance for the fourth quarter. Zepp Health expects Q4 2025 revenue to be between $82.0 million and $86.0 million, representing a year-over-year increase of 38% to 45%. This projection, while still indicating strong growth, may have fallen short of some analysts' expectations, potentially contributing to the stock's decline.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1101151083","isCrawlerRequest":true}